Antimicrobial Susceptibilities of Group B Streptococci Isolated from Patients with Invasive Disease: 10-Year Perspective
2001 ◽
Vol 45
(12)
◽
pp. 3623-3624
◽
Keyword(s):
Group B
◽
ABSTRACT Antimicrobial susceptibility testing of 192 group B streptococcal isolates from patients with invasive disease demonstrated that 31 (16%) were resistant to erythromycin and 17 (9%) were resistant to clindamycin. One isolate demonstrated high-level resistance to streptomycin, but none was highly resistant to gentamicin. Erythromycin and clindamycin are no longer reliable empirical alternatives to penicillin for the treatment and prevention of group B streptococcal infections.
2018 ◽
Vol 33
(4)
◽
pp. 114-117
1998 ◽
Vol 42
(9)
◽
pp. 2193-2196
◽
2015 ◽
Vol 40
(5)
◽
pp. 327
Comparative evaluation of VITEK 2® for antimicrobial susceptibility testing of group B Streptococcus
2007 ◽
Vol 59
(6)
◽
pp. 1109-1113
◽
2003 ◽
Vol 1
(4)
◽
pp. 273-278
◽